EnVVeno Return On Capital Employed from 2010 to 2024

NVNO Stock  USD 2.83  0.10  3.41%   
EnVVeno Medical Return On Capital Employed yearly trend continues to be very stable with very little volatility. Return On Capital Employed is likely to grow to -0.51 this year. During the period from 2010 to 2024, EnVVeno Medical Return On Capital Employed quarterly data regression pattern had range of 21.3484 and standard deviation of  4.70. View All Fundamentals
 
Return On Capital Employed  
First Reported
2010-12-31
Previous Quarter
(0.53)
Current Value
(0.51)
Quarterly Volatility
4.69965843
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check EnVVeno Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EnVVeno Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 387 K, Interest Expense of 224.9 K or Other Operating Expenses of 12.7 M, as well as many indicators such as Price To Sales Ratio of 262, Dividend Yield of 0.0 or PTB Ratio of 1.44. EnVVeno financial statements analysis is a perfect complement when working with EnVVeno Medical Valuation or Volatility modules.
  
Check out the analysis of EnVVeno Medical Correlation against competitors.

Latest EnVVeno Medical's Return On Capital Employed Growth Pattern

Below is the plot of the Return On Capital Employed of enVVeno Medical Corp over the last few years. It is EnVVeno Medical's Return On Capital Employed historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EnVVeno Medical's overall financial position and show how it may be relating to other accounts over time.
Return On Capital Employed10 Years Trend
Pretty Stable
   Return On Capital Employed   
       Timeline  

EnVVeno Return On Capital Employed Regression Statistics

Arithmetic Mean0.57
Coefficient Of Variation824.92
Mean Deviation2.19
Median0.47
Standard Deviation4.70
Sample Variance22.09
Range21.3484
R-Value(0.20)
Mean Square Error22.85
R-Squared0.04
Significance0.48
Slope(0.21)
Total Sum of Squares309.22

EnVVeno Return On Capital Employed History

2024 -0.51
2023 -0.53
2022 -0.62
2021 -0.3
2020 -1.24
2019 -4.93
2018 -3.86

About EnVVeno Medical Financial Statements

EnVVeno Medical investors utilize fundamental indicators, such as Return On Capital Employed, to predict how EnVVeno Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Return On Capital Employed(0.53)(0.51)

Pair Trading with EnVVeno Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnVVeno Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnVVeno Medical will appreciate offsetting losses from the drop in the long position's value.

Moving against EnVVeno Stock

  0.6MD Mednax IncPairCorr
  0.6ECOR Electrocore LLCPairCorr
  0.5DOCS DoximityPairCorr
  0.49VREX Varex Imaging CorpPairCorr
  0.48OM Outset MedicalPairCorr
The ability to find closely correlated positions to EnVVeno Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EnVVeno Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EnVVeno Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling enVVeno Medical Corp to buy it.
The correlation of EnVVeno Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EnVVeno Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if enVVeno Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EnVVeno Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether enVVeno Medical Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EnVVeno Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Envveno Medical Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Envveno Medical Corp Stock:
Check out the analysis of EnVVeno Medical Correlation against competitors.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.29)
Return On Assets
(0.37)
Return On Equity
(0.59)
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.